一分钟看懂
这是一项关于前列腺癌的III 期研究，登记的药物或干预包括Apalutamide；Androgen-deprivation Therapy (ADT)，当前状态为研究进行中，已停止招募。登记地点显示中国北京、长春、成都、广州等城市有研究中心记录。是否仍有名额以及是否值得进一步询问，需要向研究中心确认。
药物或干预
Apalutamide；Androgen-deprivation Therapy (ADT) · III 期
登记条件中文摘要
登记的基本范围为男性，年龄18 岁；另列出8项专业入选条件，需结合英文原文并由研究团队确认。
登记记录列出6项主要排除条件，具体医学含义需结合英文原文并由研究团队确认。
中国哪些地方有记录
以下地点来自登记信息，不代表此刻仍有名额；请向研究中心确认最新情况。
- Peking University First Hospital · 北京
- The First Hospital of Jilin University · 长春
- West China School of Medicine/West China Hospital, Sichuan University · 成都
- The First Affiliated Hospital Sun Yat sen University · 广州
- Nanfang Hospital of Southern Medical Hospital · 广州
- Shandong Provincial Hospital · 济南
- Ningbo First Hospital · 宁波
- Shengjing Hospital Of China Medical University · 沈阳
- TongJi Hospital of TongJi Medical College of Huazhong University of Science & Technology · 武汉
- The First Affiliated Hospital of Xian Jiaotong University · 西安
公开的入选条件
- * Diagnosis of prostate cancer prior to screening with histologically or cytologically confirmed adenocarcinoma of the prostate
- * For participants not undergoing Gender-affirming care: Metastatic prostate cancer disease documented by conventional imaging (example, computed tomography \[CT\], magnetic resonance imaging \[MRI\], or bone scan) and/or next-generation imaging \[NGI\] demons
- * For participants undergoing Gender-affirming care: No evidence of metastasis by either conventional imaging (example, CT, MRI, or bone scan) and/or NGI is also acceptable
- * For participants not undergoing gender-affirming care: testosterone levels \> 50 (ng/dL) nanograms per deciliter at screening, except for those who may have received ADT prior to screening. Participants are allowed to have received up to 3 months of (ADT) an
- * For participants undergoing Gender-affirming care: There is no testosterone level requirement for inclusion
- * Have an Eastern Cooperative Oncology Group Performance Status (ECOG PS) of 0 or 1. Participants with ECOG PS 2 or 3 are eligible for the study if the ECOG PS score is related to stable physical limitations (example, wheelchair-bound due to prior spinal cord
- * A participant must agree not to plan to conceive a child while enrolled in this study or within 3 months after the last dose of study treatment
- * Must be able to take whole apalutamide tablets by swallowing alone or with another vehicle (example, applesauce)
联系前需要确认
请继续确认中心是否启动、疾病分型、既往治疗、检查费用和知情同意安排。
查看登记信息
登记号：NCT05884398；登记信息更新于 2026-09-25。